These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 28336086

  • 1. Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors.
    Spielman LJ, Gibson DL, Klegeris A.
    Eur J Cell Biol; 2017 May; 96(3):240-253. PubMed ID: 28336086
    [Abstract] [Full Text] [Related]

  • 2. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D, Seino Y.
    Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
    [Abstract] [Full Text] [Related]

  • 3. Incretin actions beyond the pancreas: lessons from knockout mice.
    Yabe D, Seino Y.
    Curr Opin Pharmacol; 2013 Dec; 13(6):946-53. PubMed ID: 24095602
    [Abstract] [Full Text] [Related]

  • 4. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F, Gunawan AL, Tso P, Aponte GW.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul 01; 319(1):G23-G35. PubMed ID: 32421358
    [Abstract] [Full Text] [Related]

  • 5. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA, Bergmann NC, Knop FK.
    Diabetes Obes Metab; 2016 Sep 01; 18(9):847-54. PubMed ID: 27160961
    [Abstract] [Full Text] [Related]

  • 6. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
    Pathak V, Vasu S, Flatt PR, Irwin N.
    Diabetes Obes Metab; 2014 Apr 01; 16(4):357-65. PubMed ID: 24164718
    [Abstract] [Full Text] [Related]

  • 7. Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration.
    Kopp KO, Li Y, Glotfelty EJ, Tweedie D, Greig NH.
    Biomolecules; 2024 Jul 19; 14(7):. PubMed ID: 39062586
    [Abstract] [Full Text] [Related]

  • 8. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T, Drucker DJ.
    Regul Pept; 2005 Jun 15; 128(2):125-34. PubMed ID: 15780432
    [Abstract] [Full Text] [Related]

  • 9. Incretin-mediated control of cardiac energy metabolism.
    Chan JSF, Shafaati T, Ussher JR.
    J Endocrinol; 2024 Oct 01; 263(1):. PubMed ID: 39013412
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
    Friedrichsen BN, Neubauer N, Lee YC, Gram VK, Blume N, Petersen JS, Nielsen JH, Møldrup A.
    J Endocrinol; 2006 Mar 01; 188(3):481-92. PubMed ID: 16522728
    [Abstract] [Full Text] [Related]

  • 11. Novel extrapancreatic effects of incretin.
    Yamada Y, Tsukiyama K, Sato T, Shimizu T, Fujita H, Narita T.
    J Diabetes Investig; 2016 Apr 01; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
    [Abstract] [Full Text] [Related]

  • 12. Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
    Verma MK, Goel R, Krishnadas N, Nemmani KVS.
    Expert Opin Ther Targets; 2018 Jul 01; 22(7):615-628. PubMed ID: 29911915
    [Abstract] [Full Text] [Related]

  • 13. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N, Lynn FC, Buchan AM, Ehses J, Hinke SA, Pospisilik JA, Miyawaki K, Yamada Y, Seino Y, McIntosh CH, Pederson RA.
    Am J Physiol Endocrinol Metab; 2003 May 01; 284(5):E931-9. PubMed ID: 12540373
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells.
    Al-Zaid B, Chacko S, Ezeamuzie CI, Bünemann M, Krasel C, Karimian T, Lanzerstorfer P, Al-Sabah S.
    Pharmacol Res Perspect; 2022 Oct 01; 10(5):e01013. PubMed ID: 36177761
    [Abstract] [Full Text] [Related]

  • 15. A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus.
    Smith C, Patterson-Cross R, Woodward O, Lewis J, Chiarugi D, Merkle F, Gribble F, Reimann F, Adriaenssens A.
    Appetite; 2022 Jul 01; 174():106022. PubMed ID: 35430298
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of human incretin receptor missense variants.
    Fortin JP, Schroeder JC, Zhu Y, Beinborn M, Kopin AS.
    J Pharmacol Exp Ther; 2010 Jan 01; 332(1):274-80. PubMed ID: 19841474
    [Abstract] [Full Text] [Related]

  • 17. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
    Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, Hölscher C.
    Eur J Pharmacol; 2017 Oct 05; 812():82-90. PubMed ID: 28666800
    [Abstract] [Full Text] [Related]

  • 18. Expression of glucagon-like peptide-1 receptor and glucose‑dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells.
    Aoyama E, Watari I, Podyma-Inoue KA, Yanagishita M, Ono T.
    Int J Mol Med; 2014 Aug 05; 34(2):475-82. PubMed ID: 24866833
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
    Salles GN, Calió ML, Hölscher C, Pacheco-Soares C, Porcionatto M, Lobo AO.
    Neuropharmacology; 2020 Jan 01; 162():107813. PubMed ID: 31628935
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
    Yuliantie E, Darbalaei S, Dai A, Zhao P, Yang D, Sexton PM, Wang MW, Wootten D.
    Biochem Pharmacol; 2020 Jul 01; 177():114001. PubMed ID: 32360365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.